Morning Briefing
Summaries of health policy coverage from major news organizations
Medicare Committee Recommends Expensive Drug For Some Prostate-Cancer Patients
In a controversial review of the prostate cancer vaccine Provenge, a Medicare committee recommends that Medicare cover the costly drug for prostate-cancer patients whose disease has spread.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
